• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Landec Corporation

    2/14/24 3:39:52 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LNDC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    LIFECORE BIOMEDICAL, INC. \DE\

    (Name of Issuer)


    Common

    (Title of Class of Securities)


    514766104

    (CUSIP Number)


    12/31/2023

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    514766104


    1Names of Reporting Persons

    LW CAPITAL MANAGEMENT, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    NEW YORK
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    544,294.00
    6Shared Voting Power

    1,033,903.00
    7Sole Dispositive Power

    544,294.00
    8Shared Dispositive Power

    1,033,903.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,578,197.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.2 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    514766104


    1Names of Reporting Persons

    Laughing Water Capital, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    529,234.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    529,234.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    529,234.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.7 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    514766104


    1Names of Reporting Persons

    Laughing Water Capital II, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    504,669.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    504,669.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    504,669.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.7 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    LIFECORE BIOMEDICAL, INC. \DE\
    (b)Address of issuer's principal executive offices:

    3515 LYMAN BOULEVARD, CHASKA, MINNESOTA, 55318
    Item 2. 
    (a)Name of person filing:

    LW Capital Management, LLC
    (b)Address or principal business office or, if none, residence:

    41B North Village Road, Rockville Centre, NY 11570
    (c)Citizenship:

    New York
    (d)Title of class of securities:

    Common
    (e)CUSIP No.:

    514766104
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1,578,197
    (b)Percent of class:

    5.20  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    544,294

     (ii) Shared power to vote or to direct the vote:

    1,033,903

     (iii) Sole power to dispose or to direct the disposition of:

    544,294

     (iv) Shared power to dispose or to direct the disposition of:

    1,033,903

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    As the discretionary investment manager of Laughing Water Capital, LP (LWC) and Laughing Water Capital Fund II, LP (LWC2), LW Capital Management, LLC (LWCM) has power to direct the voting and disposition of shares held by LWC and LWC2 LP's.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    See Item(s) 2(a), 2(b), 2(c), 2(d) of Ownership Group - Laughing Water Capital, LP (LWC) and Laughing Water Capital Fund II, LP (LWC2), LW Capital Management, LLC (LWCM
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    LW CAPITAL MANAGEMENT, LLC
     
    Signature:/s/ Matthew J. Sweeney
    Name/Title:Manager & Chief Compliance Officer
    Date:02/14/2024
     
    Laughing Water Capital, LP
     
    Signature:/s/ Matthew J. Sweeney
    Name/Title:Manager & Chief Compliance Officer
    Date:02/14/2024
     
    Laughing Water Capital II, LP
     
    Signature:/s/ Matthew J. Sweeney
    Name/Title:Manager & Chief Compliance Officer
    Date:02/14/2024

    Documents

    File Name:
    LWCapitalMgtForm13G.txt
    Type:
    CORRESP
    Type:
    Description:
    LW Capital Mgt Form 13G
    Contents:
    ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICBPTUIgQVBQUk9WQUwNCiAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIE9NQiBOdW1i ZXI6IDMyMzUtMDE0NQ0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgRXhwaXJlczogRmVicnVhcnkgMjgsIDIwMDkNCiAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIEVzdGltYXRlZCBh dmVyYWdlIGJ1cmRlbg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgaG91cnMgcGVyIHJlc3BvbnNlLi4uMTAuNA0KICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0NCg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIFVO SVRFRCBTVEFURVMNCiAgICAgICAgICAgICAgICAgICAgICAgU0VDVVJJVElFUyBBTkQgRVhD SEFOR0UgQ09NTUlTU0lPTg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICBXQVNISU5H VE9OLCBELkMuIDIwNTQ5DQoNCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICBT Q0hFRFVMRSAxM0cvQQ0KICAgICAgICAgICAgICAgICAgICBVTkRFUiBUSEUgU0VDVVJJVElF UyBFWENIQU5HRSBBQ1QgT0YgMTkzNA0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICANCg0KDQogICAgICAgICAgICAgICAgICAgICAgICAgICAgTGlmZWNvcmUgQmlvbWVkaWNh bCwgSW5jLg0KIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgKE5hbWUgb2YgSXNzdWVyKQ0KDQogICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgIENPTU1PTiBTVE9DSw0KIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0NCiAgICAgICAgICAgICAgICAgICAgICAgICAoVGl0bGUgb2YgQ2xhc3Mgb2YgU2VjdXJp dGllcykNCg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgNTE0NzY2MTA0 DQoNCiAgICAgICAgICAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg IChDVVNJUCBOdW1iZXIpDQoNCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICBEZWNl bWJlciAzMSwgMjAyMw0KICAgICAgICAgIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAgICAgICAgICAgIChEYXRlIG9m IEV2ZW50IHdoaWNoIFJlcXVpcmVzIEZpbGluZyBvZiB0aGlzIFN0YXRlbWVudCkNCg0KQ0hF Q0sgVEhFIEFQUFJPUFJJQVRFIEJPWCBUTyBERVNJR05BVEUgVEhFIFJVTEUgUFVSU1VBTlQg VE8gV0hJQ0ggVEhJUyBTQ0hFRFVMRQ0KSVMgRklMRUQ6DQoNClsgXSBSVUxFIDEzRC0xKEIp DQoNCltYXSBSVUxFIDEzRC0xKEMpDQoNClsgXSBSVUxFIDEzRC0xKEQpDQoNCiAgICAgKlRI RSBSRU1BSU5ERVIgT0YgVEhJUyBDT1ZFUiBQQUdFIFNIQUxMIEJFIEZJTExFRCBPVVQgRk9S IEEgUkVQT1JUSU5HDQpQRVJTT04nUyBJTklUSUFMIEZJTElORyBPTiBUSElTIEZPUk0gV0lU SCBSRVNQRUNUIFRPIFRIRSBTVUJKRUNUIENMQVNTIE9GDQpTRUNVUklUSUVTLCBBTkQgRk9S IEFOWSBTVUJTRVFVRU5UIEFNRU5ETUVOVCBDT05UQUlOSU5HIElORk9STUFUSU9OIFdISUNI IA0KV09VTEQgQUxURVIgRElTQ0xPU1VSRVMgUFJPVklERUQgSU4gQSBQUklPUiBDT1ZFUiBQ QUdFLg0KDQogICAgIFRIRSBJTkZPUk1BVElPTiBSRVFVSVJFRCBPTiBUSEUgUkVNQUlOREVS IE9GIFRISVMgQ09WRVIgUEFHRSBTSEFMTCBOT1QgDQpCRSBERUVNRUQgVE8gQkUgIkZJTEVE IiBGT1IgVEhFIFBVUlBPU0UgT0YgU0VDVElPTiAxOCBPRiBUSEUgU0VDVVJJVElFUw0KRVhD SEFOR0UgQUNUIE9GIDE5MzQgKFRIRSAiQUNUIikgT1IgT1RIRVJXSVNFIFNVQkpFQ1QgVE8g VEhFIExJQUJJTElUSUVTIA0KT0YgVEhBVCBTRUNUSU9OIE9GIFRIRSBBQ1QgQlVUIFNIQUxM IEJFIFNVQkpFQ1QgVE8gQUxMIE9USEVSIFBST1ZJU0lPTlMgDQpPRiBUSEUgQUNUIChIT1dF VkVSLCBTRUUgVEhFIE5PVEVTKS4NCg0KDQogICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgUGFnZSAxIG9mIDEwIFBhZ2VzDQoNCjxQQUdFPg0KDQoNCg0KDQpDVVNJUCBOTy4gNTE0 NzY2MTA0DQogICAgICAgICAgLS0tLS0tLS0tDQoNCi0gLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0N CiAgMSAgICAgIE5BTUVTIE9GIFJFUE9SVElORyBQRVJTT05TDQogICAgICAgICBJLlIuUy4g SURFTlRJRklDQVRJT04gTk9TLiBPRiBBQk9WRSBQRVJTT05TIChFTlRJVElFUyBPTkxZKQ0K DQogICAgICAgICBMYXVnaGluZyBXYXRlciBDYXBpdGFsLCBMUCANCi0gLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0NCiAgMiAgICAgIENIRUNLIFRIRSBBUFBST1BSSUFURSBCT1ggSUYgQSBNRU1C RVIgT0YgQSBHUk9VUCAoU0VFIElOU1RSVUNUSU9OUykNCihhKSBbWF0NCg0KKGIpIFsgXQ0K DQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQogIDMgICAgICBTRUMgVVNFIE9OTFkNCg0KLSAt LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLQ0KICA0ICAgICAgQ0lUSVpFTlNISVAgT1IgUExBQ0UgT0Yg T1JHQU5JWkFUSU9ODQoNCg0KICAgICAgICAgIERlbGF3YXJlDQotIC0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tDQogICAgICAgICAgICAgICAgICAgICAgICAgICA1ICAgIFNPTEUgVk9USU5HIFBP V0VSDQoNCiAgICAgICAgICAgTlVNQkVSIE9GICAgICAgICAgICAgICAgICBOT05FDQogICAg ICAgICAgICBTSEFSRVMNCiAgICAgICAgICBCRU5FRklDSUFMTFkgICAgIC0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgT1dO RUQgQlkgICAgICAgIDYgICAgU0hBUkVEIFZPVElORyBQT1dFUg0KICAgICAgICAgICAgIEVB Q0gNCiAgICAgICAgICAgUkVQT1JUSU5HICAgICAgICAgICAgICAgIDUyOSwyMzQNCiAgICAg ICAgICAgIFBFUlNPTiAgICAgICAgIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICBXSVRIICAgICAgICAgIDcgICAgU09M RSBESVNQT1NJVElWRSBQT1dFUg0KDQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgTk9ORQ0KICAgICAgICAgICAgICAgICAgICAgICAgICAgLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAgICAgICAgICAgICAgICAg ICAgICAgICAgOCAgICBTSEFSRUQgRElTUE9TSVRJVkUgUE9XRVINCg0KICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgNTI5LDIzNA0KLSAtLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LQ0KICA5ICAgICBBR0dSRUdBVEUgQU1PVU5UIEJFTkVGSUNJQUxMWSBPV05FRCBCWSBFQUNI IFJFUE9SVElORyBQRVJTT04NCg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgNTI5LDIzNA0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAxMCAgICBDSEVDSyBCT1gg SUYgVEhFIEFHR1JFR0FURSBBTU9VTlQgSU4gUk9XICg5KSBFWENMVURFUyBDRVJUQUlOIFNI QVJFUyANCiAgICAgICAgWyBdIChTRUUgSU5TVFJVQ1RJT05TKQ0KDQotIC0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tDQogIDExICAgIFBFUkNFTlQgT0YgQ0xBU1MgUkVQUkVTRU5URUQgQlkgQU1P VU5UIElOIFJPVyA5ICAgMS43NCUNCg0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAxMiAg ICBUWVBFIE9GIFJFUE9SVElORyBQRVJTT04gKFNFRSBJTlNUUlVDVElPTlMpICANCiAgICAg ICAgICAgICBQTg0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KDQogICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgIFBhZ2UgMiBvZiAxMCBQYWdlcw0KPFBBR0U+DQoNCg0KDQpDVVNJ UCBOTy4gNTE0NzY2MTA0DQogICAgICAgICAgLS0tLS0tLS0tDQoNCi0gLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0NCiAgMSAgICAgIE5BTUVTIE9GIFJFUE9SVElORyBQRVJTT05TDQogICAgICAg ICBJLlIuUy4gSURFTlRJRklDQVRJT04gTk9TLiBPRiBBQk9WRSBQRVJTT05TIChFTlRJVElF UyBPTkxZKQ0KDQogICAgICAgICBMYXVnaGluZyBXYXRlciBDYXBpdGFsIElJLCBMUA0KLSAt LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAyICAgICAgQ0hFQ0sgVEhFIEFQUFJPUFJJQVRFIEJP WCBJRiBBIE1FTUJFUiBPRiBBIEdST1VQIChTRUUgSU5TVFJVQ1RJT05TKQ0KKGEpIFtYXQ0K IA0KKGIpIFsgXQ0KDQoNCi0gLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgMyAgICAgIFNFQyBV U0UgT05MWQ0KDQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQogIDQgICAgICBDSVRJWkVOU0hJ UCBPUiBQTEFDRSBPRiBPUkdBTklaQVRJT04NCg0KICAgICAgICAgIERlbGF3YXJlDQotIC0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tDQogICAgICAgICAgICAgICAgICAgICAgICAgICA1ICAgIFNP TEUgVk9USU5HIFBPV0VSDQoNCiAgICAgICAgICAgTlVNQkVSIE9GICAgICAgICAgICAgICAg IE5PTkUNCiAgICAgICAgICAgIFNIQVJFUw0KICAgICAgICAgIEJFTkVGSUNJQUxMWSAgICAg LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAg ICAgICAgICBPV05FRCBCWSAgICAgICAgNiAgICBTSEFSRUQgVk9USU5HIFBPV0VSDQogICAg ICAgICAgICAgRUFDSA0KICAgICAgICAgICBSRVBPUlRJTkcgICAgICAgICAgICAgICAgNTA0 LDY2OQ0KICAgICAgICAgICAgUEVSU09OICAgICAgICAgLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAgICAgICAgICAgIFdJVEggICAgICAg ICAgNyAgICBTT0xFIERJU1BPU0lUSVZFIFBPV0VSDQoNCiAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICBOT05FDQogICAgICAgICAgICAgICAgICAgICAgICAgICAtLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQogICAgICAg ICAgICAgICAgICAgICAgICAgICA4ICAgIFNIQVJFRCBESVNQT1NJVElWRSBQT1dFUg0KDQog ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICA1MDQsNjY5DQotIC0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tDQogIDkgICAgIEFHR1JFR0FURSBBTU9VTlQgQkVORUZJQ0lBTExZIE9X TkVEIEJZIEVBQ0ggUkVQT1JUSU5HIFBFUlNPTg0KDQogICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICA1MDQsNjY5DQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQoNCiAgMTAg ICAgQ0hFQ0sgQk9YIElGIFRIRSBBR0dSRUdBVEUgQU1PVU5UIElOIFJPVyAoOSkgRVhDTFVE RVMgQ0VSVEFJTiBTSEFSRVMNCiAgICAgICAgWyBdICAoU0VFIElOU1RSVUNUSU9OUykNCg0K LSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAxMSAgICBQRVJDRU5UQUdFIE9GIENMQVNTIFJF UFJFU0VOVEVEIEJZIEFNT1VOVCBJTiBST1cgOSAgIDEuNjclDQoNCi0gLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0NCiAgMTIgICAgVFlQRSBPRiBSRVBPUlRJTkcgUEVSU09OIChTRUUgSU5TVFJV Q1RJT05TKSAgDQogICAgICAgICAgICAgUE4NCi0gLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgUGFnZSAzIG9mIDEwIFBhZ2VzDQo8UEFH RT4NCg0KDQoNCg0KQ1VTSVAgTk8uIDUxNDc2NjEwNA0KICAgICAgICAgIC0tLS0tLS0tLQ0K DQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQogIDEgICAgICBOQU1FUyBPRiBSRVBPUlRJTkcg UEVSU09OUw0KICAgICAgICAgSS5SLlMuIElERU5USUZJQ0FUSU9OIE5PUy4gT0YgQUJPVkUg UEVSU09OUyAoRU5USVRJRVMgT05MWSkNCg0KICAgICAgICAgICBMVyBDYXBpdGFsIE1hbmFn ZW1lbnQsIExMQw0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAyICAgICAgQ0hFQ0sgVEhF IEFQUFJPUFJJQVRFIEJPWCBJRiBBIE1FTUJFUiBPRiBBIEdST1VQIChTRUUgSU5TVFJVQ1RJ T05TKQ0KKGEpIFtYXQ0KIA0KKGIpIFsgXQ0KDQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQog IDMgICAgICBTRUMgVVNFIE9OTFkNCg0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICA0ICAg ICAgQ0lUSVpFTlNISVAgT1IgUExBQ0UgT0YgT1JHQU5JWkFUSU9ODQoNCiAgICAgICAgICBE ZWxhd2FyZSANCi0gLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAgICAg ICAgICAgIDUgICAgU09MRSBWT1RJTkcgUE9XRVINCg0KICAgICAgICAgICBOVU1CRVIgT0Yg ICAgICAgICAgICAgICAgTk9ORQ0KICAgICAgICAgICAgU0hBUkVTICAgICAgICAgICAgICAg ICAgIDU0NCwyOTQNCiAgICAgICAgICBCRU5FRklDSUFMTFkgICAgIC0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgT1dORUQg QlkgICAgICAgIDYgICAgU0hBUkVEIFZPVElORyBQT1dFUg0KICAgICAgICAgICAgIEVBQ0gN CiAgICAgICAgICAgUkVQT1JUSU5HICAgICAgICAgICAgICAgMSwwMzMsOTAzDQogICAgICAg ICAgICBQRVJTT04gICAgICAgICAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tDQogICAgICAgICAgICAgV0lUSCAgICAgICAgICA3ICAgIFNPTEUg RElTUE9TSVRJVkUgUE9XRVINCg0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgIDU0NCwyOTQNCiAgICAgICAgICAgICAgICAgICAgICAgICAgIC0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAg ICAgICAgICAgIDggICAgU0hBUkVEIERJU1BPU0lUSVZFIFBPV0VSDQoNCiAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgMSwwMzMsOTAzDQotIC0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tDQogIDkgICAgIEFHR1JFR0FURSBBTU9VTlQgQkVORUZJQ0lBTExZIE9XTkVEIEJZIEVB Q0ggUkVQT1JUSU5HIFBFUlNPTg0KDQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgIDEsNTc4LDE5Nw0KLSAtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLQ0KICAxMCAgICBDSEVDSyBC T1ggSUYgVEhFIEFHR1JFR0FURSBBTU9VTlQgSU4gUk9XICg5KSBFWENMVURFUyBDRVJUQUlO IFNIQVJFUyANCiAgICAgICAgWyBdIChTRUUgSU5TVFJVQ1RJT05TKSANCg0KLSAtLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLQ0KICAxMSAgICBQRVJDRU5UIE9GIENMQVNTIFJFUFJFU0VOVEVEIEJZ IEFNT1VOVCBJTiBST1cgOSAgICA1LjIwJQ0KDQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQog IDEyICAgIFRZUEUgT0YgUkVQT1JUSU5HIFBFUlNPTiAoU0VFIElOU1RSVUNUSU9OUykgIA0K ICAgICAgICAgICAgIENPDQotIC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tDQoNCiAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgUGFnZSA0IG9mIDEwIFBhZ2VzDQo8UEFHRT4NCg0KDQoN Cg0KQ1VTSVAgTk8uIDUxNDc2NjEwNA0KICAgICAgICAgIC0tLS0tLS0tLQ0KDQotIC0tLS0t LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tDQoNCg0KDQpJVEVNIDEoQSkgICAgICAgICBOQU1FIE9GIElTU1VF UjoNCg0KICAgICAgICAgICAgICAgICAgTGlmZWNvcmUgQmlvbWVkaWNhbCwgSW5jLg0KDQpJ VEVNIDEoQikgICAgICAgICBBRERSRVNTIE9GIElTU1VFUidTIFBSSU5DSVBBTCBFWEVDVVRJ VkUgT0ZGSUNFUzoNCg0KICAgICAgICAgICAgICAgICAgMzUxNSBMeW1hbiBCb3VsZXZhcmQg DQogICAgICAgICAgICAgICAgICBDaGFza2EsIE1OIDU1MzE4DQoNCklURU0gMihhKSAgICAg ICAgIE5BTUUgT0YgUEVSU09OIEZJTElORzogDQoNCiAgICAgICAgICAgICAgICAgIChpKSBM YXVnaGluZyBXYXRlciBDYXBpdGFsLCBMUCAoTFdDKSB3aXRoIHJlc3BlY3QgdG8NCiAgICAg ICAgICAgICAgICAgICAgICBzaGFyZXMgb2YgQ29tbW9uIFN0b2NrIGRpcmVjdGx5IG93bmVk IGJ5IGl0Lg0KDQogICAgICAgICAgICAgICAgIChpaSkgTGF1Z2hpbmcgV2F0ZXIgQ2FwaXRh bCBJSSwgTFAgKExXQzIpIHdpdGggcmVzcGVjdA0KICAgICAgICAgICAgICAgICAgICAgIHRv IHNoYXJlcyBvZiBDb21tb24gU3RvY2sgZGlyZWN0bHkgb3duZWQgYnkgaXQuDQoNCiAgICAg ICAgICAgICAgICAoaWlpKSBMVyBDYXBpdGFsIE1hbmFnZW1lbnQsIExMQyAoTFdDTSkgd2l0 aCByZXNwZWN0DQogICAgICAgICAgICAgICAgICAgICAgdG8gc2hhcmVzIG9mIENvbW1vbiBT dG9jayBkaXJlY3RseSAmIGJlbmVmaWNpYWxseQ0KICAgICAgICAgICAgICAgICAgICAgIG93 bmVkIGJ5IGl0Lg0KDQogICAgICAgICAgICAgICAgICANCiAgICAgICAgICAgICAgICAgICAg ICANCg0KICAgICAgICAgICAgICAgICAgDQogICAgICAgICAgICAgICAgICAgICAgDQogICAg ICAgICAgICAgICAgICAgICAgDQogICAgICAgICAgICAgICAgICAgICAgDQoNCiAgICAgICAg ICAgICAgICAgICAgICBUaGUgZm9yZWdvaW5nIHBlcnNvbnMgYXJlIGhlcmVpbmFmdGVyIHNv bWV0aW1lcw0KICAgICAgICAgICAgICAgICBjb2xsZWN0aXZlbHkgcmVmZXJyZWQgdG8gYXMg dGhlIFJlcG9ydGluZyBQZXJzb25zLiBBbnkgDQogICAgICAgICAgICAgICAgIGRpc2Nsb3N1 cmVzIGhlcmVpbiB3aXRoIHJlc3BlY3QgdG8gcGVyc29ucyBvdGhlciB0aGFuIHRoZSANCiAg ICAgICAgICAgICAgICAgUmVwb3J0aW5nIFBlcnNvbnMgYXJlIG1hZGUgb24gaW5mb3JtYXRp b24gYW5kIGJlbGlldmUgYWZ0ZXINCiAgICAgICAgICAgICAgICAgbWFraW5nIGlucXVpcnkg dG8gdGhlIGFwcHJvcHJpYXRlIHBhcnR5LiANCg0KDQpJVEVNIDIoYikgICAgICAgIEFERFJF U1MgT0YgUFJJTkNJUEFMIEJVU0lORVNTIE9GRklDRSwgT1IgSUYgTk9ORSwgUkVTSURFTkNF Og0KDQogICAgICAgICAgICAgICAgIFRoZSBhZGRyZXNzIG9mIHRoZSBidXNpbmVzcyBvZmZp Y2Ugb2YgZWFjaCBvZiB0aGUgUmVwb3J0aW5nDQogICAgICAgICAgICAgICAgIFBlcnNvbnMg aXMgNDFCIE5vcnRoIFZpbGxhZ2UgUm9hZCwgUm9ja3ZpbGxlIENlbnRyZSwgTlkgMTE1NzAN CiAgICAgICAgICAgICAgICAgDQpJVEVNIDIoYykgICAgICAgIENJVElaRU5TSElQOg0KDQog ICAgICAgICAgICAgICAgIExXQyBhbmQgTFdDMiBhcmUgbGltaXRlZCBwYXJ0bmVyc2hpcHMg b3JnYW5pemVkIHVuZGVyIHRoZQ0KICAgICAgICAgICAgICAgICBsYXdzIG9mIHRoZSBTdGF0 ZSBvZiBEZWxhd2FyZS4gTFdDTSBpcyBhIE5ldyBZb3JrICANCiAgICAgICAgICAgICAgICAg bGltaXRlZCBsaWFiaWxpdHkgY29tcGFueS4gDQogICAgICAgICAgICAgICAgIA0KICAgICAg ICAgICAgICAgICANCg0KSVRFTSAyKGQpICAgICAgICAgVElUTEUgT0YgQ0xBU1MgT0YgU0VD VVJJVElFUzoNCg0KICAgICAgICAgICAgICAgICAgQ29tbW9uIFN0b2NrDQoNCiAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgUGFnZSA1IG9mIDEwIFBhZ2VzDQoNCjxQQUdFPg0K DQoNCklURU0gMihlKSAgICAgICAgIENVU0lQIE5VTUJFUjoNCg0KICAgICAgICAgICAgICAg ICAgNTE0NzY2MTA0IA0KDQpJVEVNIDMuICAgICAgICAgICBJRiBUSElTIFNUQVRFTUVOVCBJ UyBGSUxFRCBQVVJTVUFOVCBUTyBTUy4yNDAuMTNELTEoQikgT1IgU1MuDQogICAgICAgICAg ICAgICAgICAyNDAuMTNkLTIoQikgb3IgKEMpLCBDSEVDSyBXSEVUSEVSIFRIRSBQRVJTT04g RklMSU5HIElTIEE6IA0KICAgICAgICAgICAgICAgICAgDQogICAgICAgIChhKSBbIF0gQnJv a2VyIG9yIGRlYWxlciByZWdpc3RlcmVkIHVuZGVyIHNlY3Rpb24gMTUgb2YgdGhlIEFjdCAo MTUNCiAgICAgICAgICAgICAgICBVLlMuQy4gNzhvKS4NCg0KICAgICAgICAoYikgWyBdIEJh bmsgYXMgZGVmaW5lZCBpbiBzZWN0aW9uIDMoYSkoNikgb2YgdGhlIEFjdCANCiAgICAgICAg ICAgICAgICAoMTUgVS5TLkMuIDc4YykuDQoNCiAgICAgICAgKGMpIFsgXSBJbnN1cmFuY2Ug Y29tcGFueSBhcyBkZWZpbmVkIGluIHNlY3Rpb24gMyhhKSgxOSkgb2YgdGhlIEFjdA0KICAg ICAgICAgICAgICAgICgxNSBVLlMuQy4gNzhjKS4NCg0KICAgICAgICAoZCkgWyBdIEludmVz dG1lbnQgY29tcGFueSByZWdpc3RlcmVkIHVuZGVyIHNlY3Rpb24gOCBvZiB0aGUgDQogICAg ICAgICAgICAgICAgSW52ZXN0bWVudCBDb21wYW55IEFjdCBvZiAxOTQwICgxNSBVLlMuQy4g ODBhLTgpLg0KDQogICAgICAgIChlKSBbWF0gQW4gaW52ZXN0bWVudCBhZHZpc2VyIGluIGFj Y29yZGFuY2Ugd2l0aCANCiAgICAgICAgICAgICAgICBzcy4yNDAuMTNkLTEoYikoMSkoaWkp KEUpOw0KICAgICAgICAgICAgICAgDQogICAgICAgIChmKSBbIF0gQW4gZW1wbG95ZWUgYmVu ZWZpdCBwbGFuIG9yIGVuZG93bWVudCBmdW5kIGluIGFjY29yZGFuY2Ugd2l0aA0KICAgICAg ICAgICAgICAgIHNzLjI0MC4xM2QtMShiKSgxKShpaSkoRik7DQoNCiAgICAgICAgKGcpIFsg XSBBIHBhcmVudCBob2xkaW5nIGNvbXBhbnkgb3IgY29udHJvbCBwZXJzb24gaW4gYWNjb3Jk YW5jZSB3aXRoDQogICAgICAgICAgICAgICAgc3MuMjQwLjEzZC0xKGIpKDEpKGlpKShHKTsN Cg0KICAgICAgICAoaCkgWyBdIEEgc2F2aW5ncyBhc3NvY2lhdGlvbnMgYXMgZGVmaW5lZCBp biBTZWN0aW9uIDMoYikgb2YgdGhlDQogICAgICAgICAgICAgICAgRmVkZXJhbCBEZXBvc2l0 IEluc3VyYW5jZSBBY3QgKDEyIFUuUy5DLiAxODEzKTsNCg0KICAgICAgICAoaSkgWyBdIEEg Y2h1cmNoIHBsYW4gdGhhdCBpcyBleGNsdWRlZCBmcm9tIHRoZSBkZWZpbml0aW9uIG9mIGFu DQogICAgICAgICAgICAgICAgaW52ZXN0bWVudCBjb21wYW55IHVuZGVyIHNlY3Rpb24gMyhj KSgxNCkgb2YgdGhlIEludmVzdG1lbnQgDQogICAgICAgICAgICAgICAgQ29tcGFueSBBY3Qg b2YgMTk0MCAoMTUgVS5TLkMuIDgwYS0zKTsNCg0KICAgICAgICAoaikgWyBdIEdyb3VwLCBp biBhY2NvcmRhbmNlIHdpdGggc3MuMjQwLjEzZC0xKGIpKDEpKGlpKShKKS4NCg0KICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICBQYWdlIDYgb2YgMTAgUGFnZXMNCg0KPFBBR0U+ DQoNCklURU0gNC4gT1dORVJTSElQOg0KDQogICAgICAgIFRoaXMgU3RhdGVtZW50IGlzIGJl aW5nIGZpbGVkIHdpdGggcmVzcGVjdCB0byBhbiBhZ2dyZWdhdGUgb2YNCiAgICAgICAgMSw1 NzgsMTk3IHNoYXJlcyBvZiBDb21tb24gU3RvY2ssIHJlc3VsdGluZyBpbiBiZW5lZmljaWFs IG93bmVyc2hpcA0KICAgICAgICBhcyBmb2xsb3dzOg0KICAgICAgICANCg0KICAgICAgICAx LiBMYXVnaGluZyBXYXRlciBDYXBpdGFsLCBMUCwNCiAgICAgICAgICAgKGEpIEFtb3VudCBC ZW5lZmljaWFsbHkgb3duZWQ6IDUyOSwyMzQNCiAgICAgICAgICAgKGIpIFBlcmNlbnQgb2Yg Q2xhc3M6IDEuNzQlDQogICAgICAgICAgICAgICBUaGUgcGVyY2VudGFnZXMgdXNlZCBoZXJl aW4gYW5kIGluIHRoZSByZXN0IG9mIEl0ZW0gNCBhcmUNCiAgICAgICAgICAgICAgIGNhbGN1 bGF0ZWQgYmFzZWQgb24gMzAsMzIyLDE2OSBzaGFyZXMgb2YgQ29tbW9uIFN0b2NrDQogICAg ICAgICAgICAgICBvdXRzdGFuZGluZyBhcyBvZiBNYXkgMjYsIDIwMjMsIGFzIGRpc2Nsb3Nl ZCBpbiB0aGUNCiAgICAgICAgICAgICAgIElzc3VlcnMgRm9ybSAxMC1RIGFzIGZpbGVkIHdp dGggdGhlIFNFQw0KICAgICAgICAgICAgICAgb24gSnVuZSAyLCAyMDIzDQogICAgICAgICAg IChjKSAoaSkgU29sZSBwb3dlciB0byB2b3RlIG9yIGRpcmVjdCB0aGUgdm90ZTogLTAtDQog ICAgICAgICAgICAgIChpaSkgU2hhcmVkIHBvd2VyIHRvIHZvdGUgb3IgZGlyZWN0IHRoZSB2 b3RlOiA1MjksMjM0DQogICAgICAgICAgICAgKGlpaSkgU29sZSBwb3dlciB0byBkaXNwb3Nl IG9yIGRpcmVjdCB0aGUgZGlzcG9zaXRpb246IC0wLQ0KICAgICAgICAgICAgICAoaXYpIFNo YXJlZCBwb3dlciB0byBkaXNwb3NlIG9yIGRpcmVjdCB0aGUgZGlzcG9zaXRpb246NTI5LDIz NA0KDQogICAgICAgIDIuIExhdWdoaW5nIFdhdGVyIENhcGl0YWwgSUksIExQDQogICAgICAg ICAgIChhKSBBbW91bnQgQmVuZWZpY2lhbGx5IG93bmVkOiA1MDQsNjY5DQogICAgICAgICAg IChiKSBQZXJjZW50IG9mIENsYXNzOiAxLjY3JSAgICAgICAgIA0KICAgICAgICAgICAoYykg KGkpIFNvbGUgcG93ZXIgdG8gdm90ZSBvciBkaXJlY3QgdGhlIHZvdGU6IC0wLQ0KICAgICAg ICAgICAgICAoaWkpIFNoYXJlZCBwb3dlciB0byB2b3RlIG9yIGRpcmVjdCB0aGUgdm90ZTog NTA0LDY2OQ0KICAgICAgICAgICAgIChpaWkpIFNvbGUgcG93ZXIgdG8gZGlzcG9zZSBvciBk aXJlY3QgdGhlIGRpc3Bvc2l0aW9uOiAtMC0NCiAgICAgICAgICAgICAgKGl2KSBTaGFyZWQg cG93ZXIgdG8gZGlzcG9zZSBvciBkaXJlY3QgdGhlIGRpc3Bvc2l0aW9uOiA1MDQsNjY5DQoN CiAgICAgICAgMy4gTFcgQ2FwaXRhbCBNYW5hZ2VtZW50LCBMTEMNCiAgICAgICAgICAgKGEp IEFtb3VudCBCZW5lZmljaWFsbHkgb3duZWQ6IDEsNTc4LDE5Nw0KICAgICAgICAgICAoYikg UGVyY2VudCBvZiBDbGFzczogNS4yMCUgICAgICAgIA0KICAgICAgICAgICAoYykgKGkpIFNv bGUgcG93ZXIgdG8gdm90ZSBvciBkaXJlY3QgdGhlIHZvdGU6IDU0NCwyOTQNCiAgICAgICAg ICAgICAgKGlpKSBTaGFyZWQgcG93ZXIgdG8gdm90ZSBvciBkaXJlY3QgdGhlIHZvdGU6MSww MzMsOTAzDQogICAgICAgICAgICAgKGlpaSkgU29sZSBwb3dlciB0byBkaXNwb3NlIG9yIGRp cmVjdCB0aGUgZGlzcG9zaXRpb246IDU0NCwyOTQNCiAgICAgICAgICAgICAgKGl2KSBTaGFy ZWQgcG93ZXIgdG8gZGlzcG9zZSBvciBkaXJlY3QgdGhlIGRpc3Bvc2l0aW9uOg0KICAgICAg ICAgICAgICAgICAgIDEsMDMzLDkwMw0KDQogICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgIFBhZ2UgNyBvZiAxMCBQYWdlcw0KDQo8UEFHRT4gICAgICAgIA0KDQpJVEVNIDUuICAg ICAgICAgT1dORVJTSElQIE9GIEZJVkUgUEVSQ0VOVCBPUiBMRVNTIE9GIEEgQ0xBU1MuDQoN CiAgICAgICAgICAgICAgICAgIE4vQQ0KDQpJVEVNIDYuICAgICAgICAgT1dORVJTSElQIE9G IE1PUkUgVEhBTiBGSVZFIFBFUkNFTlQgT04gQkVIQUxGIE9GIEFOT1RIRVIgDQogICAgICAg ICAgICAgICAgUEVSU09OLg0KDQogICAgICAgICAgICAgICAgQXMgdGhlIGRpc2NyZXRpb25h cnkgaW52ZXN0bWVudCBtYW5hZ2VyIG9mIHRoZSBMV0MgYW5kIExXQzIgTFAncw0KCQlMV0NN IGhhcyBwb3dlciB0byBkaXJlY3QgdGhlIHZvdGluZyBhbmQgZGlzcG9zaXRpb24gb2YNCiAg ICAgICAgICAgICAgICBzaGFyZXMgaGVsZCBieSBMV0MgYW5kIExXQzIgTFAncy4gIA0KICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgIA0KDQpJVEVNIDcuIElERU5USUZJQ0FUSU9O IEFORCBDTEFTU0lGSUNBVElPTiBPRiBUSEUgU1VCU0lESUFSWSBXSElDSCBBQ1FVSVJFRA0K ICAgICAgICBUSEUgU0VDVVJJVFkgQkVJTkcgUkVQT1JURUQgT04gQlkgVEhFIFBBUkVOVCBI T0xESU5HIENPTVBBTlkgT1INCiAgICAgICAgQ09OVFJPTCBQRVJTT04uDQoNCiAgICAgICAg ICAgICAgICAgIE4vQQ0KDQoNCklURU0gOC4gICAgICAgICAgIElERU5USUZJQ0FUSU9OIEFO RCBDTEFTU0lGSUNBVElPTiBPRiBNRU1CRVJTIE9GIFRIRSBHUk9VUC4NCg0KDQogICAgICAg ICAgICAgICAgICBTZWUgSXRlbSAyLiANCg0KDQpJVEVNIDkuICAgICAgICAgICBOT1RJQ0Ug T0YgRElTU09MVVRJT04gT0YgR1JPVVAuDQoNCiAgICAgICAgICAgICAgICAgIE4vQQ0KDQog ICAgICAgICAgICAgICAgICANCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgUGFn ZSA4IG9mIDEwIFBhZ2VzDQoNCjxQQUdFPg0KDQpJVEVNIDEwLiAgICAgICAgICBDRVJUSUZJ Q0FUSU9OLg0KDQogICAgICAgICAgICAgICAgICBCeSBzaWduaW5nIGJlbG93IEkgY2VydGlm eSB0aGF0LCB0byB0aGUgYmVzdCBvZiBteSANCmtub3dsZWRnZSBhbmQgYmVsaWVmLCB0aGUg c2VjdXJpdGllcyByZWZlcnJlZCB0byBhYm92ZSB3ZXJlIG5vdCBhY3F1aXJlZCBhbmQNCmFy ZSBub3QgaGVsZCBmb3IgdGhlIHB1cnBvc2Ugb2Ygb3Igd2l0aCB0aGUgZWZmZWN0IG9mIGNo YW5naW5nIG9yIGluZmx1ZW5jaW5nDQp0aGUgY29udHJvbCBvZiB0aGUgaXNzdWVyIG9mIHRo ZSBzZWN1cml0aWVzIGFuZCB3ZXJlIG5vdCBhY3F1aXJlZCBhbmQgYXJlIG5vdA0KaGVsZCBp biBjb25uZWN0aW9uIHdpdGggb3IgYXMgYSBwYXJ0aWNpcGFudCBpbiBhbnkgdHJhbnNhY3Rp b24gaGF2aW5nIHRoYXQNCnB1cnBvc2Ugb3IgZWZmZWN0Lg0KDQoNCiAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgIFNJR05BVFVSRQ0KDQogICAgICAgICAgICAgICAgICBB ZnRlciByZWFzb25hYmxlIGlucXVpcnkgYW5kIHRvIHRoZSBiZXN0IG9mIG15IGtub3dsZWRn ZSANCmFuZCBiZWxpZWYsIEkgaGVyZWJ5IGNlcnRpZnkgdGhhdCB0aGUgaW5mb3JtYXRpb24g c2V0IGZvcnRoIGluIHRoaXMgc3RhdGVtZW50DQppcyB0cnVlLCBjb21wbGV0ZSBhbmQgY29y cmVjdC4NCg0KRmVicnVhcnkgMTIsIDIwMjQNCiAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAvcy8gTWF0dGhldyBKLiBTd2VlbmV5IA0KICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIC0tLS0tLS0tLS0tLS0tLS0t LS0tLS0tLS0tLS0tLS0tLS0NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICBNYW5hZ2VyICYgQ2hpZWYgQ29tcGxpYW5jZSBPZmZpY2VyDQoJCQkJCSAg ICAgIExXIENhcGl0YWwgTWFuYWdlbWVudCwgTExDIA0KICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgIA0KICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgICAgICANCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICAgICAgIA0KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgICAgICANCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg ICAgICAgDQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAg DQogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgDQogICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgDQogICAgICAgICAg ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgDQoNCg0KDQoNCg0K
    Get the next $LNDC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LNDC

    DatePrice TargetRatingAnalyst
    8/11/2022$14.00Mkt Perform → Outperform
    Barrington Research
    7/20/2022$13.00Overweight
    Stephens
    4/6/2022Outperform → Mkt Perform
    Barrington Research
    10/4/2021$15.00 → $14.00Buy
    Roth Capital
    7/30/2021$12.00 → $15.00Buy
    Roth Capital
    More analyst ratings

    $LNDC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Schechter Joshua converted options into 9,554 shares, increasing direct ownership by 20% to 57,667 units (SEC Form 4)

    4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)

    2/2/24 7:02:00 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Calloway Nathaniel converted options into 3,981 shares, increasing direct ownership by 17% to 28,069 units (SEC Form 4)

    4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)

    2/2/24 6:41:59 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Obus Nelson converted options into 9,554 shares, increasing direct ownership by 12% to 88,687 units (SEC Form 4)

    4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Issuer)

    2/2/24 6:40:32 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lifecore Biomedical Announces Completion of Corporate Name Change

    Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol "LFCR" Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com CHASKA, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has completed its transition to Lifecore Biomedical, including the change of its name from Landec Corporation to Lifecore Biomedical, Inc. In connection with this change, the Company's common stock is also expected to commence trading under its new Nasdaq ticker symbol "LFCR" tomorrow, N

    11/14/22 9:01:56 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022

    CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC) ("Lifecore" or the "Company"), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. ("Lifecore") and Curation Foods, Inc. ("Curation Foods"), – today announced that Jim Hall, CEO of Landec Corporation & President of Lifecore, and John Morberg, CFO will be hosting a fireside chat at the Stephens Annual Investment Conference in Nashville, TN. The Company will participate in a fireside chat on Thursday, November 17th at 8:00 AM CT. The live audio webcast will be available to all interested parties through a live audio webcast accessible on the Company's investor rel

    11/10/22 8:00:00 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to "LFCR" on November 14

    CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC) ("Lifecore" or the "Company") today announced that it expects to effect its previously announced corporate name change to Lifecore Biomedical, Inc. and to cause its common stock to begin trading on Nasdaq under the ticker symbol "LFCR" prior to market open on November 14, 2022. This new ticker symbol will replace the Company's current ticker symbol "LNDC," which has been used since its initial public offering in 1996. The new corporate name and ticker symbol align with the Company's ongoing strategic transformation toward its high-growth, high-value CDMO business that is focused on the development, fill and f

    11/1/22 8:00:00 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    Leadership Updates

    Live Leadership Updates

    View All

    Custom Made Meals Appoints Molly Montgomery as Chief Executive Officer

    Custom Made Meals (CMM), a leading national provider of fresh, ready-to-cook (RTC) entrees, appetizers, and sides for the meat and deli departments of retail grocery and club stores, announced today that it has appointed Molly Montgomery as CEO, effective today. Ms. Montgomery has served on the CMM Board of Directors since it was acquired by Stellex Capital Management LLC (Stellex) in May of 2021 and will continue to serve on the board in her new role. Stellex is a middle-market private investment firm with strong experience in the food industry. Ms. Montgomery succeeds Dale Easdon, who has led the Company as CEO for the past three years and has worked closely with management to ensure a sm

    5/17/22 8:30:00 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    Financials

    Live finance-specific insights

    View All

    Landec Corporation Reports First Quarter Fiscal Year 2023 Results

    Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year periodLifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter versus the prior year periodReiterates fiscal 2023 full year guidance for LifecoreCorporate rebranding to Lifecore Biomedical continues to progress SANTA MARIA, Calif. and MINNEAPOLIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC) ("Landec" or the "Company"), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. ("Lifecore") and Curation Foods, Inc. ("Curation Foods"), reported results for the fiscal 2023 first

    10/6/22 7:15:00 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET

    SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC) ("Landec" or the "Company"), a diversified health and wellness company focused on its growing Lifecore Biomedical ("Lifecore") business – a fully integrated contract development and manufacturing organization ("CDMO") that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced a change to its previously announced fiscal 2023 first quarter earnings conference call date in recognition of Yom Kippur. The Company will now report financial results before the market opens on T

    9/28/22 4:05:00 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT

    SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC) ("Landec" or the "Company"), a diversified health and wellness company focused on its growing Lifecore Biomedical ("Lifecore") business – a fully integrated contract development and manufacturing organization ("CDMO") that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it will host a conference call to discuss fiscal 2023 first quarter financial results. The live webcast can be accessed via Landec's website on the Investor Events & Presentations page. The web

    9/21/22 8:00:00 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Landec upgraded by Barrington Research with a new price target

    Barrington Research upgraded Landec from Mkt Perform to Outperform and set a new price target of $14.00

    8/11/22 9:23:39 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stephens initiated coverage on Landec with a new price target

    Stephens initiated coverage of Landec with a rating of Overweight and set a new price target of $13.00

    7/20/22 7:31:01 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Landec downgraded by Barrington Research

    Barrington Research downgraded Landec from Outperform to Mkt Perform

    4/6/22 9:22:55 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Landec Corporation (Amendment)

    SC 13G/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)

    2/9/24 9:59:14 AM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D/A filed by Landec Corporation (Amendment)

    SC 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)

    1/4/24 4:00:21 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D/A filed by Landec Corporation (Amendment)

    SC 13D/A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)

    8/15/23 5:07:46 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $LNDC
    SEC Filings

    View All

    Landec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)

    2/16/24 4:12:45 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Landec Corporation

    SCHEDULE 13G - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Subject)

    2/14/24 3:39:52 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Landec Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)

    1/12/24 4:51:33 PM ET
    $LNDC
    Biotechnology: Pharmaceutical Preparations
    Health Care